BioMarin Pharmaceutical | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



BioMarin Pharmaceutical Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.